P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

0001). Topline data were announced from a phase 3 trial evaluating ropeginterferon alfa-2b-njft (P1101), a monopegylated, long-acting interferon, in patients with essential thrombocythemia (ET).

PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood ...

A loving brother has flown across the world to donate stem cells, to help save his sister’s life after she was told she would have a maximum of two years to live without treatment. Colin ...

The idea that some apps are “must-haves” or “essentials” for your Android phone is bound to be subjective, especially with millions to consider and choose from. You might have picked up a ...

The SURPASS-ET trial demonstrated ropeginterferon alfa-2b's superior efficacy over anagrelide, achieving higher durable response rates and greater reduction in JAK2 allele burden among patients with ...

Windows 11 has been around for a few years now, and if you were an early adopter like I was, there's a good chance your computer has slowed down significantly since then. There are several reasons ...

If you want to have good-smelling homes, diffusing essential oils could be a great way to reach your goal. Whether you just enjoy their scent or are hoping to mask a litter box smell, a diffuser ...

It's the most wonderful time of the year, which means you can start playing all the holiday music you want. Luckily, R&B singers have always brought soulful and emotional depth to Christmas music ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

No difference in the number of subjects or the number of peri-operative blood units transfused was detected between the young and the old group. Three elderly subjects who underwent THA developed ...

You may occasionally receive promotional content from the Los Angeles Times. Sign up for the Essential California newsletter to start your day with expert analysis, news, features and guides from ...